THE CURE FOR GILEAD
Jeffrey Sachs
August 2, 2015
Gilead has the cure for Hepatitis C (HCV) known as Sofosbuvir, which is taken alone or in combination with other drugs. Now we need a cure for Gilead. By pressing the company to make Sofosbuvir-based therapies accessible to all who need them, the Hepatitis C epidemic in America and worldwide can be brought to an end. The lives of 5 million HCV-infected Americans and an estimated 160 million HCV-infected people worldwide are at stake.
We should hold Gilead to the following simple standard: ensure that everybody who needs Sofosbuvir or a Sofosbuvir-based combination therapy can get it at an affordable price.